Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-22

FDA Approved: EXXUA — Original Application (Aytu Therapeutics, LLC)

View source ↗

Summary

The FDA approved EXXUA (gepirone) as a new drug for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXXUA (GEPIRONE)

Snippet

ORIG AP for EXXUA (GEPIRONE)